Effects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on the incidence of breast pain

被引：0
|
作者：
Boudes, P
Ronkin, S
Korner, P
Baracat, E
Constantine, G
机构：
[1] Wyeth Ayerst Res, Collegeville, PA USA
[2] Univ Fed Sao Paulo, Sao Paulo, Brazil
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] Effects of bazedoxifene (tse-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a Chinese population
    Xu, L
    Liu, JL
    Lin, JF
    Wang, SY
    Wu, YY
    Huang, QR
    Pol, B
    Paul, K
    Jamie, T
    Chen, XX
    Julien, C
    Jean-Yves, R
    Ginger, C
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S97 - S98
  • [2] Discovery and preclinical pharmacology of TSE-424, a novel tissue selective estrogen.
    Miller, CP
    Collini, MD
    Tran, BD
    Komm, BS
    Kharode, YP
    Harris, HA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U61 - U61
  • [3] Bazedoxifene (TSE-424) is a potent inhibitor of long-term estrogen deprived breast cancer cells
    Lewis-Wambi, Joan
    Kim, Helen
    Jordan, V. Craig
    CANCER RESEARCH, 2009, 69
  • [4] Update on bazedoxifene: A novel selective estrogen receptor modulator
    Biskobing, Diane M.
    CLINICAL INTERVENTIONS IN AGING, 2007, 2 (03) : 299 - 303
  • [5] TSE-424, a novel tissue selective estrogen, reduces biochemical indices of bone metabolism in a dose related fashion.
    Ronkin, S
    Clarke, L
    Boudes, P
    Constantine, G
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S413 - S413
  • [6] SR 16234, a novel steroidal tissue selective antiestrogen: selective estrogen receptor modulator (SERM).
    Tanabe, M
    Peters, R
    Chao, W
    Ryan, K
    Jong, L
    Johansson, J
    Olsen, C
    Sato, B
    Liu, J
    Yamada, Y
    Toko, T
    Asao, T
    Yano, S
    Eshima, K
    CLINICAL CANCER RESEARCH, 1999, 5 : 3843S - 3843S
  • [7] Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis
    de Villiers, T. J.
    CLIMACTERIC, 2010, 13 (03) : 210 - 218
  • [8] Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women
    Draper, MW
    Plouffe, L
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (05): : 1110 - 1111
  • [9] Extraskeletal effects of the novel selective estrogen receptor modulator (SERM) bazedoxifene acetate (BZA): A 12-month study in ovariectomized rats.
    Komm, B. S.
    Minck, D. R.
    FERTILITY AND STERILITY, 2007, 88 : S242 - S242
  • [10] Endometrial safety of bazedoxifene, a new selective estrogen receptor modulator (SERM), in the treatment of postmenopausal (PM) osteoporosis
    Archer, David F.
    Utian, W.
    Pinkerton, Joann V.
    Menegoci, J. C.
    Chakrabarti, D.
    Chines, Arkadi A.
    Constantine, G.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1091 - 1091
12345